Magdalena Adrados

1.7k citations
52 papers · 1.2k indexed · h-index 17

Magdalena Adrados

50 papers receiving 1.1k citations

Peers

Magdalena Adrados
Comparison fields: 5 of 87
  • Oncology 512
  • Microbiology 87
  • Infectious Diseases 211
  • Pathology and Forensic Medicine 191
  • Epidemiology 336
Replace Hiroyuki Hayashi with:
Hiroyuki Hayashi Japan
Christof Iking‐Konert Germany
Allen E. Eskenazi United States
B Schleiffenbaum Switzerland
Fabiana Rizzo Italy
Toshikazu Shimbo Japan
Alain Gey France
Jonathan H. Esensten United States
CE van der Schoot Netherlands
Marie‐Claude Crevon France
Magdalena Adrados relative to Hiroyuki Hayashi Japan Hiroyuki Hayashi's profile →
Citations per field
00.5×7.3×
Hiroyuki Hayashi · 1×
Citations per year

Countries citing papers authored by Magdalena Adrados

Since Specialization
Citations

This map shows the geographic impact of Magdalena Adrados's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Adrados with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Adrados more than expected).

Fields of papers citing papers by Magdalena Adrados

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdalena Adrados. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Adrados. The network helps show where Magdalena Adrados may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Magdalena Adrados, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Magdalena Adrados Line = papers co-authored together Magdalena Adrados links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20211
2 202024
3 202019
4 20195
5 2019192
6 20181
7 201843
8 20186
9 20155
10 20149
11 20141
12 2012138
13 201135
14 201023
15 20102
16 20028
17 20004
18 199223
19 1992297
20 199111

About Magdalena Adrados

Magdalena Adrados is a scholar working on Microbiology, Oncology and Infectious Diseases, having authored 52 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Neuroendocrine Tumor Research Advances (6 papers), Tuberculosis Research and Epidemiology (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Viral-associated cancers and disorders (4 papers), Neuroblastoma Research and Treatments (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Infectious Diseases and Tuberculosis (4 papers). The work is most often cited by research in Oncology (512 citations), Microbiology (87 citations) and Infectious Diseases (211 citations). Magdalena Adrados has collaborated with scholars based in Spain, Mexico and United States. Frequent co-authors include F Laguna, Juan González‐Lahoz, Teresa Vicente, Juan Berenguer, Emilio Bouza, Santiago Moreno, Mónica Marazuela, Ana M. Ramos‐Leví, O. Donnay and Vilma Pacheco-Barcía. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026